Physician profile
Mark Goodman
NPI 1609018860
$1,219.10
in general payments reported to CMS, 2019-2025
20 companies · $279 in 2025
The $279 reported for 2025 was more than what 85% of Emergency Medical Services providers received nationally (typical 2025 total: $70.35).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $36.11 · 2021: $35.30 · 2022: $251 · 2023: $230 · 2024: $257 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $477.26 | 2022-2025 | Eterna, Proclaim |
| Boston Scientific Corporation | $188.25 | 2019-2025 | General - Therapies, General - Pain Management |
| Saluda Medical Americas, INC. | $78.39 | 2025 | Evoke |
| Pacira Pharmaceuticals Incorporated | $65.51 | 2022-2024 | Iovera |
| Bioventus LLC | $49.17 | 2024 | Durolane |
| Vertos Medical, INC. | $46.17 | 2024 | Mild Device Kit |
| Sanofi-Aventis U.S. LLC | $39.78 | 2019-2020 | |
| Avanos Medical | $35.30 | 2021 | |
| Nevro Corp. | $31.00 | 2024 | Senza |
| Pacira Therapeutics, INC. | $25.80 | 2019 | |
| Ge Healthcare | $24.75 | 2019 | |
| Biotronik Nro, INC. | $24.72 | 2025 | Prospera |
| Amgen INC. | $23.33 | 2019 | |
| Medtronic, INC. | $18.92 | 2025 | Synchromedii |
| Phathom Pharmaceuticals, INC. | $17.51 | 2024 | Voquezna |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossur Americas, INC. | $16.83 | 2024 | Miami J |
| Depuy Synthes Sales INC. | $16.05 | 2025 | Monovisc |
| Ferring Pharmaceuticals INC. | $14.44 | 2019 | |
| Si-Bone, INC. | $13.90 | 2024 | |
| Pfizer INC. | $12.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.